A RANDOMIZED PHASE 2 STUDY OF ELOTUZUMAB WITH LENALIDOMIDE AND LOW-DOSE DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

被引：0

作者：

Moreau, P. ^{[1
]}

Richardson, P. ^{[2
]}

Jakubowiak, A. ^{[3
]}

Jagannath, S. ^{[4
]}

Raab, M. ^{[5
]}

Facon, T. ^{[6
]}

Vij, R. ^{[7
]}

Reece, D. ^{[8
]}

White, D. ^{[9
,10
]}

Benboubker, L. ^{[11
]}

Zonder, J. ^{[12
]}

Rossi, J. F. ^{[13
]}

Tsao, C. ^{[14
]}

Parli, T. ^{[14
]}

Kroog, G. ^{[15
]}

Singhal, A. ^{[14
]}

Lonial, S. ^{[16
]}

机构：

[1] Univ Hosp, Nantes, France

[2] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA

[3] Univ Chicago, Med Ctr, Chicago, IL 60637 USA

[4] Mt Sinai Med Ctr, New York, NY 10029 USA

[5] Heidelberg Univ, Heidelberg, Germany

[6] Hop Claude Huriez, Lille, France

[7] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA

[8] Princess Margaret Hosp, Toronto, ON, Canada

[9] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada

[10] Dalhousie Univ Bethune, Halifax, NS, Canada

[11] CHU Tours, Hop Bretonneau, Tours, France

[12] Wayne State Univ, Detroit, MI USA

[13] CHU Montpellier, Hop St Eloi, Montpellier, France

[14] Abbott Biotherapeut Corp, Redwood City, CA USA

[15] Bristol Myers Squibb, Princeton, NJ USA

[16] Emory Univ, Sch Med, Atlanta, GA USA

来源：

HAEMATOLOGICA | 2012年 / 97卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1145

引用

页码：474 / 474

页数：1